Summary
Increasing lines of evidence indicate that obesity is an important risk factor for the exacerbation of alcoholic liver disease (ALD) and nonalcoholic steatohepatitis (NASH). Leptin, an obese gene product, is a cytokine-type hormone mainly produced from adipose tissue. Recently, it has been demonstrated that serum leptin levels are increased in patients with alcoholic cirrhosis. In this study, therefore, we investigated the role of leptin in hepatic fibrogenesis. Activated hepatic stellate cells (HSCs) produced leptin during hepatic fibrogenesis. Xenobiotic-induced hepatic fibrogenesis was almost completely abolished in ob/ob mice and Zucker (fa/fa) rats, which are inborn leptin- and leptin receptor (Ob-R)-deficient animals, respectively. Further, leptin increased transforming growth factor (TGF)-ß mRNA in isolated sinusoidal endothelial cells and Kupffer cells.Moreover, leptin augmented platelet-derived growth factor (PDGF)-dependent proliferation of HSCs. Taken together, these findings lead to the postulation that leptin acts as a profibrogenic cytokine in the sinusoidal microenvironment. In conclusion, leptin most likely plays a pivotal role in the progression of hepatic fibrosis in a variety of chronic liver diseases, including NASH.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425–432
McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC (1998) Gender dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 115: 947–953
Potter JJ, Womack L, Mezey E, Anania FA (1998) Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 244: 178–182
Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei Y, Sato N (2001) Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 34: 288–297
Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI (1995) Identification and expression cloning of a leptin receptor Ob-R. Cell 83: 1263–1271
Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh HG, Lee JI, Friedman JM (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632–635
Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, Nakao K (1996) Molecular cloning of rat leptin receptor isoform complementary DNAs—identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem. Biophys. Res. Commun. 225: 75–83
Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, Kitamura T, Takei Y, Sato N (2002) Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 36: 12–21
Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, Lang T, Fukuda T, Yamashina S, Kitamura T, Sato N (2002) Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 122: 1399–1410
Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA (2002) Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 35: 762–771
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Tokyo
About this paper
Cite this paper
Ikejima, K., Lang, T., Yamashina, S., Enomoto, N., Takei, Y., Sato, N. (2005). Role of Leptin in Pathogenesis of NASH. In: Okita, K. (eds) NASH and Nutritional Therapy. Springer, Tokyo. https://doi.org/10.1007/4-431-27172-4_2
Download citation
DOI: https://doi.org/10.1007/4-431-27172-4_2
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-21388-8
Online ISBN: 978-4-431-27172-7
eBook Packages: MedicineMedicine (R0)